Is SARS-CoV-2 important for multiple sclerosis?

被引：0
|
作者：
Chyzhyk, V. [1 ]
Sialitski, M.
Boika, A. [1 ]
Bahamaz, V.
Mazurenka, K. [1 ]
Ponomarev, V. [1 ]
机构：
[1] Dept Neurol & Neurosurg, Minsk, BELARUS
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-084
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [31] Safety of a third SARS-CoV-2 mRNA vaccine dose in people with multiple sclerosis
    Rasmussen, T. H.
    Konig, M.
    Lorentzen, A. R.
    Schikora-Rustad, S.
    Berge, T.
    Holmoy, T.
    Torkildsen, O.
    Wergeland, S.
    Overas, M. H.
    Hogestol, E. A.
    Torgauten, H. M.
    Harbo, H. F.
    Celius, E. G.
    Munthe, L. A.
    Vaage, J. T.
    Johansen, F. L.
    Nygaard, G. O.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 480 - 481
  • [32] SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action?
    Rommer, Paulus S.
    Bsteh, Gabriel
    Berger, Thomas
    Zettl, Uwe Klaus
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (01) : 165 - 167
  • [33] Low prevalence of SARS-COV-2 antibodies in people with multiple sclerosis residing in massachusetts
    Klawiter, E.
    Smith, J.
    Brewer, K.
    Stockel, K.
    Fischinger, S.
    Luedemann, C.
    Bien, H.
    Russo, A.
    Vaeth, A.
    Bakshi, R.
    Bhattacharyya, S.
    Cabot, A.
    George, I.
    Gillani, R.
    Hickey, M.
    Houtchens, M.
    Kaplan, T. Bockow
    Kimbrough, D.
    Kister, I.
    Mateen, F.
    Matiello, M.
    Severson, C.
    Singhal, T.
    Stankiewicz, J.
    Stazzone, L.
    Weiner, H.
    Zurawski, J.
    Eloyan, A.
    Chitnis, T.
    Alter, G.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 107 - 107
  • [34] Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
    Hamzavi, Seyedeh Sadigheh
    Bahrololoom, Rosemina
    Saeb, Sepideh
    Marandi, Nahid Heydari
    Hosseini, Marzieh
    Abadi, Alimohammad Keshtvarz Hesam
    Jamalidoust, Marzieh
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [35] SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort
    van Kempen, Zoe L. E.
    Strijbis, Eva M. M.
    Al, Marissa M. C. T.
    Steenhuis, Maurice
    Uitdehaag, Bernard M. J.
    Rispens, Theo
    Killestein, Joep
    JAMA NEUROLOGY, 2021, 78 (07) : 880 - 882
  • [36] Vaccine Hesitancy in Patients With Multiple Sclerosis Preparing for the SARS-CoV-2 Vaccination Challenge
    Diem, Lara
    Friedli, Christoph
    Chan, Andrew
    Salmen, Anke
    Hoepner, Robert
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (03):
  • [37] Multiple sclerosis, rituximab, SARS-CoV-2 vaccination, and COVID-19 severity
    Smith, J.
    Gonzales, E.
    Zhuang, Z.
    Li, B.
    Langer-Gould, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 651 - 651
  • [38] Effect of SARS-CoV-2 vaccination on natural killer cell responses in multiple sclerosis
    Laroni, A.
    Capaia, M.
    Lusi, V.
    Casella, V.
    Della Valle, I.
    Franciotta, D.
    Sormani, M. P.
    Vigo, T.
    Inglese, M.
    Lapucci, C.
    Grifoni, A.
    Sette, A.
    Raposo, C.
    De Palma, R.
    Fenoglio, D.
    Pedotti, R.
    Uccelli, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 623 - 624
  • [39] SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad
    Amor, Sandra
    Baker, David
    Khoury, Samia J.
    Schmierer, Klaus
    Giovanonni, Gavin
    ANNALS OF NEUROLOGY, 2020, 87 (06) : 794 - 797
  • [40] Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects
    Maniscalco, Giorgia Teresa
    Ferrara, Anne Lise
    Liotti, Antonietta
    Manzo, Valentino
    Di Battista, Maria Elena
    Salvatore, Simona
    Graziano, Daniela
    Viola, Assunta
    Amato, Gerardino
    Moreggia, Ornella
    Cesare, Daniele Di Giulio
    Alfieri, Gennaro
    Di Iorio, Walter
    Della Rocca, Gennaro
    Andreone, Vincenzo
    De Rosa, Veronica
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
12345